Thiourea-functionalized aminoglutethimide derivatives as anti-leishmanial agents.

IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Future medicinal chemistry Pub Date : 2024-08-02 Epub Date: 2024-07-02 DOI:10.1080/17568919.2024.2359362
Muhammad Sajid, Hina Siddiqui, Humaira Zafar, Sammer Yousuf, Michael D Threadgill, Muhammad Iqbal Choudhary
{"title":"Thiourea-functionalized aminoglutethimide derivatives as anti-leishmanial agents.","authors":"Muhammad Sajid, Hina Siddiqui, Humaira Zafar, Sammer Yousuf, Michael D Threadgill, Muhammad Iqbal Choudhary","doi":"10.1080/17568919.2024.2359362","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> We aim to develop new anti-leishmanial agents against <i>Leishmania major</i> and <i>Leishmania tropica</i>.<b>Materials & methods:</b> A total of 23 thiourea derivatives of (±)-aminoglutethimide were synthesized and evaluated for <i>in vitro</i> activity against promastigotes of <i>L. major</i> and <i>L. tropica</i>.<b>Results & conclusion:</b> The <i>N</i>-benzoyl analogue <b>7p</b> was found potent (IC<sub>50</sub> = 12.7 μM) against <i>L. major</i> and non toxic to normal cells. The docking studies, indicates that these inhibitors may target folate and glycolytic pathways of the parasite. The <i>N</i>-hexyl compound <b>7v</b> was found strongly active against both species, and lacked cytotoxicity against normal cells, whereas compound <b>7r</b>, with a 3,5-bis-(tri-fluoro-methyl)phenyl unit, was active against <i>Leishmania</i>, but was cytotoxic in nature. Compound <b>7v</b> was thus identified as a hit for further studies.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":" ","pages":"1485-1497"},"PeriodicalIF":3.2000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370960/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17568919.2024.2359362","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: We aim to develop new anti-leishmanial agents against Leishmania major and Leishmania tropica.Materials & methods: A total of 23 thiourea derivatives of (±)-aminoglutethimide were synthesized and evaluated for in vitro activity against promastigotes of L. major and L. tropica.Results & conclusion: The N-benzoyl analogue 7p was found potent (IC50 = 12.7 μM) against L. major and non toxic to normal cells. The docking studies, indicates that these inhibitors may target folate and glycolytic pathways of the parasite. The N-hexyl compound 7v was found strongly active against both species, and lacked cytotoxicity against normal cells, whereas compound 7r, with a 3,5-bis-(tri-fluoro-methyl)phenyl unit, was active against Leishmania, but was cytotoxic in nature. Compound 7v was thus identified as a hit for further studies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
硫脲官能化氨基丁亚胺衍生物作为抗利什曼病药。
目的:我们的目标是开发新的抗利什曼病原体制剂,以对付大利什曼病原体和热带利什曼病原体。材料与方法:合成了 23 种 (±)-aminoglutethimide 的硫脲衍生物,并评估了它们对大利什曼原虫和热带利什曼原虫的体外活性。结果与结论:结果表明,N-苯甲酰基类似物 7p 对大肠杆菌有效(IC50 = 12.7 μM),对正常细胞无毒。对接研究表明,这些抑制剂可能针对寄生虫的叶酸和糖酵解途径。发现 N-己基化合物 7v 对这两种寄生虫都有很强的活性,但对正常细胞没有细胞毒性,而具有 3,5-双(三氟甲基)苯基单元的化合物 7r 对利什曼原虫有活性,但具有细胞毒性。因此,化合物 7v 被确定为有待进一步研究的热门化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Future medicinal chemistry
Future medicinal chemistry CHEMISTRY, MEDICINAL-
CiteScore
5.80
自引率
2.40%
发文量
118
审稿时长
4-8 weeks
期刊介绍: Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.
期刊最新文献
A comprehensive insight into naphthalimides as novel structural skeleton of multitargeting promising antibiotics. A call to develop tramadol enantiomer for overcoming the tramadol crisis by reducing addiction. Advancements in PROTAC-based therapies for neurodegenerative diseases. EGFR molecular degraders: preclinical successes and the road ahead. How does machine learning augment alchemical binding free energy calculations?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1